Juan Saavedra

Affiliations: 
 
Google:
"Juan Saavedra"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Villapol S, Kryndushkin D, Balarezo MG, et al. (2015) Hepatic Expression of Serum Amyloid A1 Is Induced by Traumatic Brain Injury and Modulated by Telmisartan. The American Journal of Pathology. 185: 2641-52
Villapol S, Balarezo MG, Affram K, et al. (2015) Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain : a Journal of Neurology. 138: 3299-315
Hafko R, Villapol S, Nostramo R, et al. (2013) Commercially available angiotensin II Atâ‚‚ receptor antibodies are nonspecific. Plos One. 8: e69234
Nostramo R, Tillinger A, Saavedra JM, et al. (2012) Regulation of angiotensin II type 2 receptor gene expression in the adrenal medulla by acute and repeated immobilization stress. The Journal of Endocrinology. 215: 291-301
Villapol S, Yaszemski AK, Logan TT, et al. (2012) Candesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2817-29
Benicky J, Sánchez-Lemus E, Honda M, et al. (2011) Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 857-70
Macova M, Pavel J, Saavedra JM. (2009) A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH. Brain Research. 1250: 130-40
Zhou J, Pavel J, Macova M, et al. (2006) AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke; a Journal of Cerebral Circulation. 37: 1271-6
Saavedra JM. (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cellular and Molecular Neurobiology. 25: 485-512
Seltzer A, Bregonzio C, Armando I, et al. (2004) Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Research. 1028: 9-18
See more...